“Republicans would have you believe that the drug and insurance companies have sacrificed profits in the name of competition, but nothing could be farther from the truth,” said Rep. Pete Stark, D-Calif. “In fact, the dirty little secret is that costs are lower because of low enrollment and a slowdown in drug spending.”

Read more on this topic.